HB 2152: A Compassionate Step Forward for Washington Patients
On March 11, Governor Bob Ferguson signed HB 2152, a bill that allows qualifying terminal patients to use medical cannabis in hospitals, nursing homes, and hospice facilities under defined policies. The law takes effect June 11, 2026, and facilities must implement patient-use policies beginning January 1, 2027.
At its core, the legislation is about dignity.
HB 2152, also known as Ryan’s Law, recognizes that medical cannabis can play a meaningful role in improving quality of life for patients facing terminal illness and encourages health care facilities to adopt policies allowing its use while maintaining safety protocols.
For many families, that recognition matters deeply. End-of-life care should prioritize comfort, autonomy, and compassion. For patients who rely on medical cannabis to manage pain, nausea, anxiety, or appetite loss, being forced to discontinue use when entering a hospital or hospice setting has long created unnecessary suffering. HB 2152 affirms that compassionate care should not end at the doors of a hospital or hospice facility.
The passage of HB 2152 also highlights something important about the path Washington has taken since legalization.
When voters approved Initiative 502 in 2012, Washington became one of the first states in the nation to legalize cannabis for adult use. That moment marked a profound shift in public policy. Yet the transition from prohibition to regulation was not simple, and for medical patients it has often meant navigating a system that changed dramatically around them.
The creation of the regulated market brought many benefits: product testing, consumer protections, licensed businesses, and clear statewide rules. These are important accomplishments. But the regulatory structure also had consequences for patients. In many ways, adult use has represented a form of re-criminalization for patients and compassionate care providers who operated more freely within earlier medical frameworks.
Collective gardens disappeared. Informal caregiver networks were pushed aside. Patients who had once accessed medicine through community-based systems suddenly faced new compliance requirements and fewer options. Over the past decade, The Cannabis Alliance has worked to bridge that gap by supporting a responsible regulatory system while continuing to fight for policies that protect patients’ access to the medicine they rely on.
HB 2152 does not radically restructure the medical program. It does something quieter, but equally important. It acknowledges that compassionate care must have a place within our regulated system. End-of-life care is rarely defined by sweeping medical breakthroughs. More often, it is shaped by small improvements that make difficult moments more manageable: relief from pain, the ability to rest, the return of appetite, or simply the chance to spend meaningful time with loved ones.
For those who have walked through end-of-life care with someone they love, those “small improvements” are not small at all. They can mean the difference between a day lost to the haze of opioid pain management and precious lucid hours gained with family and loved ones.
By ensuring that terminal patients are not forced to abandon a treatment that brings relief simply because they enter a hospital or hospice facility, Washington is taking a step toward aligning policy with humanity.
A decade later, progress sometimes arrives in small but meaningful ways.
For patients and families navigating the most difficult moments of life, this is one of those moments.